Inhaled nitric oxide to treat intermediate risk pulmonary embolism: A multicenter randomized controlled trial

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health (UM1HL113203-01, UM1HL113203)
  • Mallinckrodt Pharmaceuticals (UM1HL113203-01, UM1HL113203)
  • Foundation for the National Institutes of Health (UM1HL113203-01, UM1HL113203)
  • Edward Mallinckrodt, Jr. Foundation (UM1HL113203-01, UM1HL113203)

This publication has 27 references indexed in Scilit: